(called Collagen-OKSM MEFs) or from iPSCs originating from ROSA26-rtTA MEFs carrying two copies of a doxycycline-inducible lentiviral vector expressing the same polycistronic OKSM cassette (called Lenti-OKSM MEFs) 7 (Fig. 1b) . Upon culture in the presence of doxycycline, both Collagen-OKSM MEFs and Lenti-OKSM MEFs formed colonies with ESC-like morphology that stained positive for pluripotency-associated markers such as alkaline phosphatase, Nanog and endogenous Oct4 ( Fig. 1c and Supplementary Fig. 2 ). Such colonies could be expanded apparently indefinitely (>25 passages when submitting this manuscript) in the absence of exogenous factor expression, and we will refer to them as iPSCs. Collagen-OKSM MEFs produced iPSC colonies approximately tenfold more efficiently than Lenti-OKSM MEFs (Fig. 1d,e) , consistent with the observation that Collagen-OKSM MEFs homogenously expressed exogenous Oct4 after addition of doxycycline to the cultures, whereas we observed only patchy reactivation in Lenti-OKSM MEFs (Fig. 1f) . Collagen-MEF iPSCs formed highly differentiated teratomas in severe combined immunodeficient (SCID) mice (Fig. 1g ) and contributed to adult coat color chimeras (Fig. 1h) . These cells supported the development of 'all-iPSC' midgestation fetuses after injection into tetraploid blastocysts (Fig. 1i) , further demonstrating pluripotency.
To track cells undergoing reprogramming, we labeled Collagen-OKSM MEFs with a constitutively active lentiviral vector expressing the reporter gene tdTomato. We established MEF cultures from chimeric embryos and plated brightly red-fluorescent cells at singlecell density onto irradiated feeder cells. MEFs expressing the four reprogramming factors were smaller and proliferated faster within the first 48 h of doxycycline administration compared to uninduced cells. This resulted in clusters of coalescent cells between days 4 and 6, from which iPSC colonies emerged between days 8 and 14 of culture (Supplementary Fig. 3 ). Withdrawal of doxycycline at different time points showed that the first stably reprogrammed cells appeared by day 7, consistent with previous reports using lentiviral vectors 2, 3 (Supplementary Fig. 4a ). When we withdrew doxycycline before day 7, MEFs that had undergone morphological changes reverted back to a fibroblast-like shape and ceased proliferation (Supplementary Fig. 4a ). Re-exposure of these cells to doxycycline after 1 week of withdrawal did not yield stable iPSC colonies from more than 100 regressed colonies assayed, suggesting that these cells had become refractory to reprogramming, possibly owing to the exhaustion of their proliferative capacity 9 . The observation that cells undergoing reprogramming revert to a fibroblast-like state upon premature withdrawal of doxycycline suggests that previously reported 'partially reprogrammed cells' 10, 11 are not a common phenotype during factormediated reprogramming but rather may be the consequence The study of the molecular mechanisms underlying this conversion is hampered by the low efficiency of reprogramming and by the requirement to introduce the reprogramming factors into target cells. To circumvent these constraints, 'secondary systems' have been developed, which are based on iPSCs made with doxycycline-inducible lentiviruses [2] [3] [4] [5] [6] .
Secondary systems based on viral vectors have several limitations. First, many iPSC lines show viral transgene silencing, leading to heterogeneous expression and thus variable results. Second, viral integrations at random genomic locations can alter endogenous gene expression. Third, the breeding of mice derived from such iPSCs is complicated by the need to screen their offspring for multiple viral transgenes. To develop an improved reprogramming system, we placed a doxycycline-inducible polycistronic cassette encoding the four reprogramming factors Oct4, Klf4, Sox2 and c-Myc (OKSM) 7 in the 3′ untranslated region of the collagen type I, alpha 1 gene (Col1a1, herein referred to as Collagen) 8 (Fig. 1a) . This gene targeting was mediated by Flp recombinase and was performed in embryonic stem cells (ESCs) that express an optimized reverse tetracycline-dependent transactivator (M2-rtTA) from the ubiquitously expressed Gt(ROSA)26Sor (Rosa26) locus 8 . We refer to this allele as Rosa26-rtTA.
The OKSM cassette integrated into the Collagen locus in 12 of 12 picked ESC clones named Collagen-OKSM ESCs ( Supplementary  Fig. 1 ). To test the function of this transgenic system in comparison to a viral secondary system, we isolated mouse embryonic fibroblasts (MEFs) derived from either Collagen-OKSM ESCs of incomplete retroviral transgene silencing, which drives continuous cell proliferation without acquisition of pluripotency.
We next established a mouse strain carrying the inducible reprogramming cassette in all tissues. We bred Collagen-OKSM chimeras ( Fig. 2a) with mice that carried the EGFP gene in the Pou5f1 (also known as Oct4) locus, which serves as a faithful indicator for the acquisition of pluripotency 12 . We will refer to the resulting mice as 'reprogrammable mice' (Fig. 2b) . Notably, some reprogrammable mice developed a single aggressively growing tumor that histologically presented as a largely undifferentiated teratoma ( Supplementary Fig. 5a,b) . This phenotype is likely due to leaky transgene expression in an undefined cell type and raises the possibility that somatic cells can be reprogrammed into pluripotent cells not only in vitro but also in vivo.
To validate the Collagen-OKSM-Oct4-EGFP reprogramming system, we grew postnatal tail-tip fibroblasts (TTFs) in the presence of doxycycline, which resulted in the formation of green fluorescent ESC-like colonies at a frequency of approximately 0.1% (Fig. 2c,d ). The lower reprogramming efficiency of TTFs compared to that of MEFs ( Fig. 1e) was not due to incomplete reactivation of the reprogramming cassette (data not shown), indicating that fetal fibroblasts are more amenable to reprogramming than postnatal cells, as recently reported 13 . The efficiency of TTF reprogramming increased approximately twofold when we grew the cells in medium containing serum replacement (Fig. 2d) . These iPSCs adopted an ESC-like morphology faster than cells in serum-containing medium, consistent with previous observations 14 . In the absence of feeder layers, TTFs grown in serum-replacement medium had to be seeded at a high density (~10,000 cells cm −2 ) to reach optimal reprogramming efficiencies compared to cells grown in serum-containing medium, which required a sparse starting culture (~1,000 cells cm −2 ) (Fig. 2e) . Together, these results suggest that reprogramming is not entirely cell-autonomous but is influenced by both inhibitory and supportive signals from the culture environment.
Collagen-OKSM TTFs homozygous for the Rosa26-rtTA allele reached reprogramming efficiencies of 0.5-1% (Fig. 2d) and reprogrammed faster than heterozygous cells, as demonstrated by the earlier appearance of doxycycline-independent green fluorescent colonies (Fig. 2f) . This shows that higher levels of transgene expression are favorable for both reprogramming kinetics and efficiency.
To reprogram a defined somatic cell lineage, we isolated different hematopoietic cell types from adult reprogrammable mice (Supplementary Fig. 6 ). We consistently did not obtain iPSC colonies from mature T cells, B cells and granulocytes heterozygous for both Rosa26-rtTA and Collagen-OKSM, although we occasionally observed colonies from monocytes with this genotype (Fig. 2g) . In contrast, Collagen-OKSM heterozygous cells that were homozygous for Rosa26-rtTA reproducibly gave rise to green fluorescent iPSCs from all tested cell types at frequencies ranging from 0.01% (B cells) to 0.3% (monocytes) (Fig. 2g and Supplementary Fig. 7 ). This suggests that a critical level of factor expression is required for reprogramming of terminally differentiated blood cells. In contrast, hematopoietic stem cells and granulocyte-macrophage progenitors from Rosa26-rtTA heterozygous mice generated iPSCs at high (5-10%) efficiencies (Fig. 2h) , consistent with our previous finding that reprogramming potential inversely correlates with differentiation stage 15 . Notably, we derived iPSCs from hematopoietic stem cells homozygous for Rosa26-rtTA at frequencies of up to 40% (Fig. 2h) , which is to our knowledge the highest reprogramming efficiency for an adult somatic cell type.
Reprogramming of blood cells was equally successful in the presence or absence of cell type-specific cytokines supporting hematopoietic cell survival and proliferation, with two exceptions. First, granulocytes did not form iPSCs in the presence of the growth factor granulocyte-macrophage colony stimulating factor, and second, Rosa26-rtTA heterozygous hematopoietic stem cells and granulocyte-macrophage progenitors reprogrammed 3-4 times less efficiently without cytokines (Figs. 2g,h) . Rosa26 homozygous hematopoietic stem cells and granulocytemacrophage progenitors did not show this effect (Fig. 2h) , suggesting that higher expression levels of reprogramming factors can substitute for the signals provided by cytokines.
The mouse strain described here overcomes several of the limitations of viral secondary reprogramming systems and should be a useful tool to study the mechanisms underlying the conversion of somatic cell types into iPSCs. It may be especially attractive for dissecting the biochemistry of induced pluripotency in the context of adult stem and progenitor cells that reprogram at high efficiency. Another crucial question that can be addressed with this system is whether ESCs and iPSCs are molecularly and functionally equivalent. Specifically, the possibility to compare ESCs to genetically matched iPSCs from different tissues will allow this question to be resolved. online methods Mice. Derivation, handling and genotyping of Oct4-EGFP 12 and ROSA26-rtTA 8 mice were described previously. Collagen-OKSM reprogrammable mice will be deposited with The Jackson Laboratories once the colony has been expanded. All animal studies were carried following approved guidelines of the animal protocol of the Massachusetts General Hospital Cancer Center.
Cell culture. ESCs and iPSCs were cultured in ESC medium (DMEM with 15% FBS, L-glutamine, penicillin-streptomycin, nonessential amino acids, β-mercaptoethanol and 1,000 U ml −1 LIF) on irradiated feeder cells. ESC-derived MEFs were isolated by trypsin digestion of midgestation (E14.5) chimeric embryos followed by culture in fibroblast medium (DMEM with 10% FBS, l-glutamine, penicillinstreptomycin, nonessential amino acids and β-mercaptoethanol) containing puromycin. TTF cultures were established from tail-tip biopsies of newborn (3-8 d) mice and maintained in fibroblast medium. Hematopoietic cells were isolated from peripheral blood and bone marrow as previously described 15 .
Gene targeting of ESCs.
A polycistronic cassette encoding Oct4, Klf4, Sox2 and c-myc 7 was cloned into the shuttle plasmid pBS31 using NotI and ClaI digestion. The resulting plasmid was electroporated into KH2 ESCs together with a plasmid driving expression of Flp recombinase 8 . Correct targeted clones were screened for by hygromycin selection and confirmed by Southern blotting as previously described 8 .
Lentiviral vectors.
To produce infectious viral particles, 293T cells cultured on T75 flasks were transfected with a lentiviral vector expressing tdTomato from the ubiquitin promoter (11 µg) together with the packaging plasmids VSV-G (5.5 µg) and ∆8.9 (8.25 µg) using Fugene (Roche) transfection reagent. Viral supernatants were collected on 3 consecutive days starting 24 h after transfection, yielding a total of ~50 ml of supernatant per virus. Viral supernatant was concentrated ~200-fold by ultracentrifugation at 60,000g for 1.5 h at 4 °C and resuspension in 250 µl of PBS. Viral concentrates were stored at −80 °C. iPSCs were transduced in 0.2 ml ES medium containing 5 µg ml −1 polybrene using 20-40 µl of viral concentrate on a 48-well plate. Regular ESC medium was added 24 h after infection and red-fluorescent iPSCs isolated by flow cytometry.
Immunofluorescence. iPSCs were cultured on pretreated cover slips, fixed with 4% PFA and permeabilized with 0.5% Triton X-100. The cells were then stained with primary antibodies to mOct4 (Santa Cruz, sc-8628) and to mNanog (Abcam, ab21603), followed by staining with the respective secondary antibodies conjugated to either Alexa Fluor 488 or 546 (Invitrogen). Nuclei were counterstained with DAPI (Invitrogen). Cells were imaged using a Leica DMI4000B inverted fluorescence microscope equipped with a Leica DFC350FX camera. Images were processed and analyzed using Adobe Photoshop software.
Teratoma formation. iPSCs were collected by trypsinization and injected into the flanks of nonobese diabetic (NOD)-SCID mice, using ~5 million cells per injection. Mice were killed 3 weeks later, and teratomas were isolated and processed for histological analysis.
Blastocyst injections. Female BDF1 mice were superovulated by intraperitoneal injection of pregnant mare serum (PMS) and human chorionic gonadotropin (hCG) and mated to BDF1 stud males. Zygotes were isolated from females with a vaginal plug 24 h after hCG injection. Zygotes for diploid (2n) blastocyst injections were cultured for 3 d in EmbryoMax KSOM medium (Millipore); blastocysts were identified, injected with ESCs or iPSCs and transferred into pseudopregnant recipient females. For tetraploid (4n) blastocyst injections, zygotes were cultured overnight until they reached the 2-cell stage, at which point they were electrofused. One hour later, 1-cell embryos were carefully identified and separated from embryos that did not fuse, cultured in KSOM for another 2 d and then injected.
